Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02667444 · ClinicalTrials.gov registry record · Phase 3
P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne
A Phase 3 study, sponsored by Novan.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,330
- Enrollment target
NCT02667444: Completed Phase 3 study, sponsored by Novan.
NCT02667444 is a Phase 3 study that has completed, run by Novan. The registered enrollment target is 1,330 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (72% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02667444, a Phase 3 study, has completed, sponsored by Novan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,330 participants
- Enrollment target
Study Summary
This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.
Primary Outcome
The absolute change from Baseline in inflammatory lesion counts was to be assessed on the face only (forehead, right and left cheeks, chin, and nose). Inflammatory lesions included papules, pustules, nodules, and cysts.
Interventions
- DRUG Vehicle Gel
- DRUG SB204 4%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,330 participants |
| Start Date | 2016-02-19 |
| Est. Completion | 2016-12-09 |
| Phase | Phase 3 |
What the finished NCT02667444 record still lists
NCT02667444 is an interventional study that assigns participants to a tested intervention. Its 1,330 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (72% higher).
The record links to 0 conditions, and to 2 interventions - of which Vehicle Gel is the first listed.
NCT02667444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02667444 about?
NCT02667444 is a clinical study titled "P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne". This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.
What is the current status of trial NCT02667444?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,330 participants. The study started on 2016-02-19. Estimated completion is 2016-12-09.
What interventions are being tested in trial NCT02667444?
The interventions under investigation include: Vehicle Gel (DRUG), SB204 4% (DRUG).
Who is sponsoring clinical trial NCT02667444?
This trial is sponsored by Novan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02667444's enrollment target sits among peer trials
1,330 183rd of 2000 higher than 1,818 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05536011 · 1,329 participants
WAKIX® (Pitolisant) Pregnancy Registry
- NCT05415761 · 1,332 participants · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
- NCT05511298 · 1,332 participants
Empowering Students Project
- NCT06934876 · 1,332 participants
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI